Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Cell-penetrating peptide wikipedia , lookup
Cell culture wikipedia , lookup
Secreted frizzled-related protein 1 wikipedia , lookup
Gene expression wikipedia , lookup
List of types of proteins wikipedia , lookup
Protein adsorption wikipedia , lookup
Two-hybrid screening wikipedia , lookup
Biochemical cascade wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
Antibody to bcl-2 Oncoprotein Catalogue No: VP-B201 Product Specifications Intended use: For in-vitro diagnostic use. Mouse Monoclonal Anti-Human bcl-2 oncoprotein is intended for immunohistochemistry methodologies. A differential diagnosis is complemented by using a panel of antibodies and in conjunction with morphological studies, patient clinical history and other diagnostic tests by a qualified pathologist. A translocation occurs in a high percentage of follicular lymphomas which positions the bcl-2 against immunoglobulin heavy chain gene, with resulting overexpression of bcl-2. Bcl-2 is expressed as a 26kD protein that lies within the cell and is thought to act as an inhibitor of apoptosis. Bcl-2 expression is, therefore, inhibited in germinal centres where apoptosis forms part of the B cell production pathway. Storage and stability: Store at 2-8° C. Do not freeze. Do not use after expiration date on vial. Specificity: Human bcl-2 oncoprotein. Clone: bcl-2/100/D5 Ig Class: IgG1 Mouse IgG conc: See details on vial label Immunogen: Synthetic peptide sequence (GAAPAPGIFSSQPGC-COOH). Product: 1ml liquid tissue culture supernatant containing 15mM sodium azide. Precautions: As this product is derived from biological material proper handling procedures should be employed. Sodium azide is not considered hazardous at 15mM. However, an MSDS is available on request or online (www.vectorlabs.com) for safety or disposal information. Specimen Preparation Paraffin sections: VP-B201 can be used on paraffin wax embedded tissue fixed in 10% neutral buffered formalin. Pretreatment of tissue is essential using a high temperature antigen unmasking technique. Optimal results can be achieved with Vector Antigen Unmasking solution (H-3300). Frozen sections: Yes. INSTRUCTIONS FOR USE Dilutions and times are only a guide, there may be variations due to fixation, specimen collection and preparation, optimal conditions should be established by the individual laboratory. Following antigen unmasking of paraffin wax embedded tissue VP-B201 should be applied to sections in the dilution range 1:80 o for 60 minutes at 25 C. Positive control tissue: A positive control should be used in each run. The recommended control tissue is tonsil. Negative control tissue: A negative control tissue should be set up to verify the specificity of the antibody. The recommended negative control is cerebellum. Negative control reagent: A negative control mouse immunoglobulin (e.g. I-2000) should be used to evaluate nonspecific binding. Visualisation: ® VECTASTAIN Elite ABC Peroxidase Kits (PK-6200 or PK-6102, PK-7200) in conjunction with substrate kits (SK-4100 or SK4800) are all recommended for use with this antibody. Specific protocols are included in each kit. For professional use only. Selected References: von Haefen C, Wieder T, Gillissen B et al. (2002) Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells. Oncogene 21(25):4009. Takes RP, Baatenburg de Jong RJ, Wijffels K et al. (2001) Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer. Journal of Pathology 194:298. LeBrun D P, Kamel O W, Cleary M L, et al. (1992) Follicular lymphomas of the gastrointestinal tract. Pathologic features in 31 cases and bcl-2 oncogenic protein expression. American Journal of Pathology 140 :1327. Liu Y J, Mason D Y, Johnson G D, et al. (1991) Germinal centre cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. European Journal of Immunology 21 :1905. Hockenbery D, Nunez G, Milliman C, et al. (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348 :334. Pezella F, Tse A G D, Cordell J L, et al. (1990) Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. American Journal of Pathology 137 :225. Authorised representative: Vector Laboratories Ltd 3 Accent Park Bakewell Road Orton Southgate Peterborough PE2 6XS, U.K. Tel: 01733 237999 • Fax: 01733 237119 Vector Laboratories Inc.• 30 Ingold Road • Burlingame • CA 94010 USA Tel: (650) 697-3600 • Fax: (650) 697-0339 Email: [email protected] • Web site: www.vectorlabs.com bcl-2/VP-B201/rev 06-04